Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
04/26/2024 | ||||||||||||
Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Averages | $493.98 | 3.0% | 13.1 | 2.6% | 62% | 66 | 64.2 | 8.3% | ||||
Coca-Cola | KO | 1.96 | $61.74 | $120.92 | 24.5% | 5.1% | 21.0 | 3.2% | 86% | 95 | 91 | 9.5% |
Novartis | NVS | 1.11 | $99.06 | $110.21 | 22.3% | 4.9% | 18.0 | 3.1% | 92% | 88 | 94 | 9.5% |
Pfizer | PFE | 2.77 | $25.26 | $70.03 | 14.2% | 3.4% | 12.0 | 4.1% | 69% | 70 | 81 | 15.3% |
Roche Holdings* | RHHBY | 2.21 | $30.02 | $66.36 | 13.4% | 1.0% | 17.0 | 4.0% | 79% | 96 | 71 | 12.7% |
Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 25.6% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |